The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
Open accessAbstract
The adaptive immune system plays a pivotal role in the host’s ability to mount an effective, antigen-specific immune response against tumors. CD8+tumor-infiltrating lymphocytes (TILs) mediate tumor rejection through recognition of tumor antigens and direct killing of transformed cells. In growing tumors, TILs are often functionally impaired as a result of interaction with, or signals from, transformed cells and the tumor microenvironment. These interactions and signals can lead to transcriptional, functional, and phenotypic changes in TILs that diminish the host’s ability to eradicate the tumor. In addition to effector and memory CD8+T cells, populations described as exhausted, anergic, senescent, and regulatory CD8+T cells have been observed in clinical and basic studies of antitumor immune responses. In the context of antitumor immunity, these CD8+T cell subsets remain poorly characterized in terms of fate-specific biomarkers and transcription factor profiles. Here we discuss the current characterization of CD8+T cell fates in antitumor immune responses and discuss recent insights into how signals in the tumor microenvironment influence TIL transcriptional networks to promote CD8+T cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“Memory CD8 + T cells were subdivided in 1999 into two broad subsets, central memory (T CM ) and effector memory (T EM ), distinguished by the relative expression of two homing molecules, CD62L and CCR7 [23–25].”
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 4×
“On the other hand, CD8 T cell exhaustion is an eventual state of T cell dysfunction that occurs in progressive stages and varies depending on the context and abundance of antigen [29, 31, 105].”
InfluentialRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192527 · Cited by 2,389
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“Similarly, studies in both mice and humans have demonstrated that memory CD8 + T cells develop in vivo following adoptive transfer, maintain effector capabilities, and mediate tumor regression [65, 66].”
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · cited 1×
“This cell population proliferated more efficiently and elicited better antitumor immune responses as compared to TCM, suggesting that the TSCM population might yield more objective antitumor responses owing to its less-differentiated state and increased proliferative potential [72].”
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952 · cited 1×
“Upon secondary antigen challenge, both subsets give rise to progeny that differentiate into T EFF [27, 28, 56].”
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
Rosenberg, S. A., Spiess, P., & Lafreniere, R. (1986) · Science · doi:10.1126/science.3489291 · Cited by 1,880
Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E., & Rosenberg, S. A. (2009) · Blood · doi:10.1182/blood-2008-12-195792 · Cited by 1,766
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Fourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C., Gasink, C. R., Kaech, S. M., Miller, J. D., et al. (2005) · Nature Immunology · doi:10.1038/ni1268 · Cited by 1,266
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Overcoming T cell exhaustion in infection and cancer
Pauken, K. E., & Wherry, E. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.008 · Cited by 1,171
T-cell exhaustion in the tumor microenvironment
Jiang, Y., Li, Y., & Zhu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.162 · Cited by 1,157
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Gros, A., Robbins, P. F., Yao, X., Li, Y. F., Turcotte, S., Tran, E., Wunderlich, J. R., Mixon, A., Farid, S., Dudley, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73639 · Cited by 1,111
Brenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073
Tissue-Resident Memory T Cells
Schenkel, J. M., & Masopust, D. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.007 · Cited by 1,059
Molecular and Functional Profiling of Memory CD8 T Cell Differentiation
Kaech, S. M., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 982
Klebanoff, C. A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A. R., Finkelstein, S. E., Palmer, D. C., Antony, P. A., Hwang, S. T., Rosenberg, S. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503726102 · Cited by 969
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Effector and Memory CTL Differentiation
Williams, M. A., & Bevan, M. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141548 · Cited by 949
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., Bikoff, E. K., Robertson, E. J., Lauer, G. M., Reiner, S. L., et al. (2012) · Science · doi:10.1126/science.1229620 · Cited by 902
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Memory CD8 T-Cell Differentiation during Viral Infection
Wherry, E. J., & Ahmed, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5535-5545.2004 · Cited by 868
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.006 · Cited by 857 · cited 1×
“NFAT regulates the expression of PD-1 and Tim-3 and thus may contribute to CD8 + T cell exhaustion in chronic viral infection and cancer [139].”
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
Arbonés, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J., & Teddert, T. F. (1994) · Immunity · doi:10.1016/1074-7613(94)90076-0 · Cited by 831
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806
Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
Duraiswamy, J., Kaluza, K. M., Freeman, G. J., & Coukos, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4100 · Cited by 745
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates
Sarkar, S., Kalia, V., Haining, W. N., Konieczny, B. T., Subramaniam, S., & Ahmed, R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071641 · Cited by 633
Djenidi, F., Adam, J., Goubar, A., Durgeau, A., Meurice, G., de Montpréville, V., Validire, P., Besse, B., & Mami-Chouaib, F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402711 · Cited by 622
Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J., Calame, K., & Kaech, S. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.014 · Cited by 611
Kalia, V., Sarkar, S., Subramaniam, S., Haining, W. N., Smith, K. A., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.010 · Cited by 587
T-Cell Tolerance: Central and Peripheral
Xing, Y., & Hogquist, K. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006957 · Cited by 576
Grosso, J. F., Kelleher, C. C., Harris, T. J., Maris, C. H., Hipkiss, E. L., De Marzo, A., Anders, R., Netto, G., Getnet, D., Bruno, T. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31184 · Cited by 547
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W. L., & Massagué, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506517102 · Cited by 532
Quigley, M., Pereyra, F., Nilsson, B., Porichis, F., Fonseca, C., Eichbaum, Q., Julg, B., Jesneck, J. L., Brosnahan, K., Imam, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2232 · Cited by 517
CD8 + T‐cell memory in tumor immunology and immunotherapy
Klebanoff, C. A., Gattinoni, L., & Restifo, N. P. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00391.x · Cited by 511 · cited 1×
“Similarly, studies in both mice and humans have demonstrated that memory CD8 + T cells develop in vivo following adoptive transfer, maintain effector capabilities, and mediate tumor regression [65, 66].”
Mempel, T. R., Pittet, M. J., Khazaie, K., Weninger, W., Weissleder, R., von Boehmer, H., & von Andrian, U. H. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.015 · Cited by 488
Kao, C., Oestreich, K. J., Paley, M. A., Crawford, A., Angelosanto, J. M., Ali, M.-A. A., Intlekofer, A. M., Boss, J. M., Reiner, S. L., Weinmann, A. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.2046 · Cited by 484
Shin, H., Blackburn, S. D., Intlekofer, A. M., Kao, C., Angelosanto, J. M., Reiner, S. L., & Wherry, E. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.019 · Cited by 481
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202642 · Cited by 436
NFATc1 Regulates PD-1 Expression upon T Cell Activation
Oestreich, K. J., Yoon, H., Ahmed, R., & Boss, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4832 · Cited by 416
PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Yamamoto, R., Nishikori, M., Kitawaki, T., Sakai, T., Hishizawa, M., Tashima, M., Kondo, T., Ohmori, K., Kurata, M., Hayashi, T., et al. (2008) · Blood · doi:10.1182/blood-2007-05-085159 · Cited by 401
Kurachi, M., Barnitz, R. A., Yosef, N., Odorizzi, P. M., DiIorio, M. A., Lemieux, M. E., Yates, K., Godec, J., Klatt, M. G., Regev, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2834 · Cited by 394
Kmiecik, J., Poli, A., Brons, N. H. C., Waha, A., Eide, G. E., Enger, P. Ø., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.013 · Cited by 389
Rosenberg, S. A., & Dudley, M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405730101 · Cited by 364
Zippelius, A., Batard, P., Rubio-Godoy, V., Bioley, G., Liénard, D., Lejeune, F., Rimoldi, D., Guillaume, P., Meidenbauer, N., Mackensen, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3066 · Cited by 361
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
Complexities of TGF-β Targeted Cancer Therapy
Connolly, E. C., Freimuth, J., & Akhurst, R. J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4564 · Cited by 345
The role of CD8+ T‐cell replicative senescence in human aging
Effros, R. B., Dagarag, M., Spaulding, C., & Man, J. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00259.x · Cited by 336 · cited 1×
“It is well known that T SEN have implications in human ageing, but their role in cancer is less clear [42].”
Strength of PD-1 signaling differentially affects T-cell effector functions
Wei, F., Zhong, S., Ma, Z., Kong, H., Medvec, A., Ahmed, R., Freeman, G. J., Krogsgaard, M., & Riley, J. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305394110 · Cited by 304
Features of responding T cells in cancer and chronic infection
Kim, P. S., & Ahmed, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.005 · Cited by 297
Buggert, M., Tauriainen, J., Yamamoto, T., Frederiksen, J., Ivarsson, M. A., Michaëlsson, J., Lund, O., Hejdeman, B., Jansson, M., Sönnerborg, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004251 · Cited by 296
Powell, D. J., Dudley, M. E., Robbins, P. F., & Rosenberg, S. A. (2005) · Blood · doi:10.1182/blood-2004-06-2482 · Cited by 293
Bachmann, M. F., Wolint, P., Schwarz, K., Jäger, P., & Oxenius, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4686 · Cited by 276
Floc'h, A. L., Jalil, A., Vergnon, I., Chansac, B. L. M., Lazar, V., Bismuth, G., Chouaib, S., & Mami-Chouaib, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061524 · Cited by 269
Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissue
Chaput, N., Louafi, S., Bardier, A., Charlotte, F., Vaillant, J.-C., Ménégaux, F., Rosenzwajg, M., Lemoine, F., Klatzmann, D., & Taieb, J. (2009) · Gut · doi:10.1136/gut.2008.158824 · Cited by 264
Targeting the transforming growth factor-β signaling pathway in human cancer
Nagaraj, N. S., & Datta, P. K. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903382609 · Cited by 262
Legat, A., Speiser, D. E., Pircher, H., Zehn, D., & Fuertes Marraco, S. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00455 · Cited by 250
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Thompson, E. D., Enriquez, H. L., Fu, Y.-X., & Engelhard, V. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092454 · Cited by 249
Duraiswamy, J., Ibegbu, C. C., Masopust, D., Miller, J. D., Araki, K., Doho, G. H., Tata, P., Gupta, S., Zilliox, M. J., Nakaya, H. I., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001783 · Cited by 246
Inhibitory Receptors Beyond T Cell Exhaustion
Fuertes Marraco, S. A., Neubert, N. J., Verdeil, G., & Speiser, D. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00310 · Cited by 244
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Chikuma, S., Terawaki, S., Hayashi, T., Nabeshima, R., Yoshida, T., Shibayama, S., Okazaki, T., & Honjo, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900080 · Cited by 231
Filaci, G., Fenoglio, D., Fravega, M., Ansaldo, G., Borgonovo, G., Traverso, P., Villaggio, B., Ferrera, A., Kunkl, A., Rizzi, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4323 · Cited by 228
Surface markers of lymphocyte activation and markers of cell proliferation
Shipkova, M., & Wieland, E. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.006 · Cited by 210
Allison, J. P. (2015) · JAMA · doi:10.1001/jama.2015.11929 · Cited by 207
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
Javelaud, D., Mohammad, K. S., McKenna, C. R., Fournier, P., Luciani, F., Niewolna, M., André, J., Delmas, V., Larue, L., Guise, T. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3950 · Cited by 195
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
Zhu, Y., Ju, S., Chen, E., Dai, S., Li, C., Morel, P., Liu, L., Zhang, X., & Lu, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000749 · Cited by 189
Meloni, F., Morosini, M., Solari, N., Passadore, I., Nascimbene, C., Novo, M., Ferrari, M., Cosentino, M., Marino, F., Pozzi, E., et al. (2006) · Human Immunology · doi:10.1016/j.humimm.2005.11.005 · Cited by 169
Gehring, A. J., Ho, Z. Z., Tan, A. T., Aung, M. O., Lee, K. H., Tan, K. C., Lim, S. G., & Bertoletti, A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.045 · Cited by 169
Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State
Schietinger, A., Delrow, J. J., Basom, R. S., Blattman, J. N., & Greenberg, P. D. (2012) · Science · doi:10.1126/science.1214277 · Cited by 169
Tumor Antigens are Constitutively Presented in the Draining Lymph Nodes
Marzo, A. L., Lake, R. A., Lo, D., Sherman, L., McWilliam, A., Nelson, D., Robinson, B. W. S., & Scott, B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5838 · Cited by 166
Lu, P., Youngblood, B., Austin, J. W., Mohammed, A. U. R., Butler, R., Ahmed, R., & Boss, J. M. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130208 · Cited by 165
Filaci, G., Fravega, M., Negrini, S., Procopio, F., Fenoglio, D., Rizzi, M., Brenci, S., Contini, P., Olive, D., Ghio, M., et al. (2004) · Human Immunology · doi:10.1016/j.humimm.2003.12.001 · Cited by 163
Chapuis, A. G., Thompson, J. A., Margolin, K. A., Rodmyre, R., Lai, I. P., Dowdy, K., Farrar, E. A., Bhatia, S., Sabath, D. E., Cao, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113748109 · Cited by 163
PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
Fourcade, J., Kudela, P., Sun, Z., Shen, H., Land, S. R., Lenzner, D., Guillaume, P., Luescher, I. F., Sander, C., Ferrone, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803245 · Cited by 161
Tsukishiro, T., Donnenberg, A. D., & Whiteside, T. L. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0395-6 · Cited by 158
The three main stumbling blocks for anticancer T cells
Baitsch, L., Marraco, S. A. F., Legat, A., Meyer, C., & Speiser, D. E. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.006 · Cited by 150
Immune recognition of self in immunity against cancer
Houghton, A. N., & Guevara-Patino, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22685 · Cited by 150
Current Advances in T-Cell-Based Cancer Immunotherapy
Wang, M., Yin, B., Wang, H. Y., & Wang, R. (2014) · Immunotherapy · doi:10.2217/imt.14.86 · Cited by 147
Hidden Memories: Frontline Memory T Cells and Early Pathogen Interception
Masopust, D., & Picker, L. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102695 · Cited by 145
Fellner, C. (2012) · Europe PMC (PubMed Central) · Cited by 139
Beckhove, P., Feuerer, M., Dolenc, M., Schütz, F., Choi, C., Sommerfeldt, N., Schwendemann, J., Ehlert, K., Altevogt, P., Bastert, G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20278 · Cited by 138
Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression
Lin, R., Chen, L., Chen, G., Hu, C., Jiang, S., Sevilla, J., Wan, Y., Sampson, J. H., Zhu, B., & Li, Q.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76561 · Cited by 133
Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion
Montes, C. L., Chapoval, A. I., Nelson, J., Orhue, V., Zhang, X., Schulze, D. H., Strome, S. E., & Gastman, B. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2282 · Cited by 127
Molecular regulation of T‐cell anergy
Zheng, Y., Zha, Y., & Gajewski, T. F. (2008) · EMBO Reports · doi:10.1038/sj.embor.7401138 · Cited by 122
Stephen, T. L., Rutkowski, M. R., Allegrezza, M. J., Perales‐Puchalt, A., Tesone, A. J., Svoronos, N., Nguyen, J. M., Sarmin, F., Borowsky, M. E., Tchou, J. C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.012 · Cited by 120
Palmer, D. C., Balasubramaniam, S., Hanada, K., Wrzesinski, C., Yu, Z., Farid, S. S., Theoret, M. R., Hwang, L. N., Klebanoff, C. A., Gattinoni, L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7209 · Cited by 114
A2 T cell subsets and T cell-mediated immunity
Broere, F., Apasov, S. G., Sitkovsky, M. V., & van Eden, W. (2011) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0136-8_2 · Cited by 104
ENGEL, A. ‐., Svane, I. M., Rygaard, J., & Werdelin, O. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-419.x · Cited by 101
Mayer, C. T., Floess, S., Baru, A. M., Lahl, K., Huehn, J., & Sparwasser, T. D. (2011) · European Journal of Immunology · doi:10.1002/eji.201040913 · Cited by 100
The contributions of T‐cell anergy to peripheral T‐cell tolerance
Lechler, R. I., Chai, J., Marelli‐Berg, F. M., & Lombardi, G. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01250.x · Cited by 99
Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
Saito, H., Kuroda, H., Matsunaga, T., Osaki, T., & Ikeguchi, M. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23281 · Cited by 94
Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
Mokrani, M., Klibi, J., Bluteau, D., Bismuth, G., & Mami‐Chouaib, F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302192 · Cited by 86
Clinical Development of Immune Checkpoint Inhibitors
Ito, A., Kondo, S., Tada, K., & Kitano, S. (2015) · BioMed Research International · doi:10.1155/2015/605478 · Cited by 79
Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes
Yang, O. O., Lin, H., Dagarag, M., Ng, H. L., Effros, R. B., & Uittenbogaart, C. H. (2005) · Virology · doi:10.1016/j.virol.2004.11.028 · Cited by 79
Li, G., Yang, Q., Zhu, Y., Wang, H., Chen, X., Zhang, X., & Lu, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067401 · Cited by 78
Tumor Antigen Cross‐Presentation and the Dendritic Cell: Where it All Begins?
McDonnell, A. M., Robinson, B. W. S., & Currie, A. J. (2010) · Journal of Immunology Research · doi:10.1155/2010/539519 · Cited by 76
Redundancy of Direct Priming and Cross-Priming in Tumor-Specific CD8+ T Cell Responses
Wolkers, M. C., Stoetter, G., Vyth‐Dreese, F. A., & Schumacher, T. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3577 · Cited by 75
T cell-NF-κB activation is required for tumor control in vivo
Barnes, S. E., Wang, Y., Chen, L., Molinero, L. L., Gajewski, T. F., Evaristo, C., & Alegre, M. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-014-0045-x · Cited by 75
Ghosh, P., Sica, A., Young, H. A., Ye, J., Franco, J. L., Wiltrout, R. H., Longo, D. L., Rice, N. R., & Komschlies, K. L. (1994) · PubMed · Cited by 72
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants
Kaluza, K. M., Thompson, J., Kottke, T. J., Gilmer, H. C. F., Knutson, D. L., & Vile, R. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26447 · Cited by 60
Ikaros Imposes a Barrier to CD8+ T Cell Differentiation by Restricting Autocrine IL-2 Production
O’Brien, S., Thomas, R. M., Wertheim, G. B. W., Zhang, F., Shen, H., & Wells, A. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301992 · Cited by 53
Ramello, M. C., Tosello, J., Canale, F. P., Mena, H. A., Negrotto, S., Gastman, B., Gruppi, A., Rodríguez, E. V. A., & Montes, C. L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.451 · Cited by 52
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer
Losi, L., Bouzourène, H., & Benhattar, J. (2007) · Oncology Reports · doi:10.3892/or.17.5.1095 · Cited by 52
Engel, A., Svane, I. M., Mouritsen, S., Rygaard, J., Clausen, J. T., & Werdelin, O. (1996) · Apmis · doi:10.1111/j.1699-0463.1996.tb04923.x · Cited by 48
Bai, X., Gao, J., Liu, J., Wen, J., Zheng, P., & Liu, Y. (2001) · PubMed · Cited by 47
Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors
Liu, B., Podack, E. R., Allison, J. P., & Malek, T. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1117 · Cited by 45
Wu, F., Zhang, W., Shao, H., Bo, H., Shen, H., Li, J., Liu, Y., Wang, T., Ma, W., & Huang, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.009 · Cited by 45
Transcriptional regulation of T cell tolerance
Bandyopadhyay, S., Soto-Nieves, N., & Macián, F. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.006 · Cited by 44
Srinivasan, M., & Frauwirth, K. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3734 · Cited by 42
Berrien-Elliott, M. M., Yuan, J., Swier, L. E., Jackson, S. R., Chen, C. L., Donlin, M. J., & Teague, R. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0159 · Cited by 42
Onyema, O. O., Decoster, L., Njemini, R., Forti, L. N., Bautmans, I., Waele, M. D., & Mets, T. F. (2015) · BMC Cancer · doi:10.1186/s12885-015-2013-3 · Cited by 41
Clavijo, P. E., & Frauwirth, K. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100793 · Cited by 40
TGF‐β downregulates KLRG1 expression in mouse and human CD8+ T cells
Schwartzkopff, S., Woyciechowski, S., Aichele, U., Flecken, T., Zhang, N., Thimme, R., & Pircher, H. (2015) · European Journal of Immunology · doi:10.1002/eji.201545634 · Cited by 38
Zhang, Y., Pfannenstiel, L. W., Bolesta, E., Montes, C. L., Zhang, X., Chapoval, A. I., Gartenhaus, R. B., Strome, S. E., & Gastman, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3328 · Cited by 34
di Bari, M. G., Lutsiak, M. E. C., Takai, S., Mostböck, S., Farsaci, B., Semnani, R. T., Wakefield, L. M., Schlom, J., & Sabzevari, H. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0692-9 · Cited by 32
Straetemans, T., Berrevoets, C., Coccoris, M., Treffers-Westerlaken, E., Wijers, R., Cole, D. K., Dardalhon, V., Sewell, A. K., Taylor, N. N., Verweij, J., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.215 · Cited by 27
Wang, L.-X., Kjærgaard, J., Cohen, P. A., Shu, S., & Plautz, G. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3462 · Cited by 25
Effector CD8+ T cells activated in vitro confer immediate and long‐term tumor protection in vivo
Perret, R., & Ronchese, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838483 · Cited by 19
Pilch, H., Hoehn, H., Schmidt, M., Steiner, E. A., Tanner, B., Seufert, R., & Maeurer, M. J. (2002) · Zentralblatt für Gynäkologie · doi:10.1055/s-2002-38130 · Cited by 18
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T Cells
Quatromoni, J. G., Suzuki, E., Okusanya, O. T., Judy, B. F., Bhojnagarwala, P. S., Venegas, O. G., Eruslanov, E. B., Predina, J. D., Albelda, S. Μ., & Singhal, S. K. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-30 · Cited by 14
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity
Waugh, K. A., Leach, S. M., & Slansky, J. E. (2015) · Vaccines · doi:10.3390/vaccines3030771 · Cited by 14
Papatriantafyllou, M. (2011) · Nature reviews. Immunology · doi:10.1038/nri3098 · Cited by 7
Cited by
Siddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S. A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S. J., Scarpellino, L., Gfeller, D., Pradervand, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.021 · Cited by 1,679
Immunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 960
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Fu, C., & Jiang, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03059 · Cited by 598
Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment
Zhao, Y., Shao, Q., & Peng, G. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0344-8 · Cited by 382
Cancer vaccines: Building a bridge over troubled waters
Sellars, M. C., Wu, C. J., & Fritsch, E. F. (2022) · Cell · doi:10.1016/j.cell.2022.06.035 · Cited by 318
Metadata
- Authors
- Reiser, J., & Banerjee, A.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-14
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2401056916
- Cited by
- 255
- References
- 157
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.